Celemics, Inc. (KOSDAQ:331920)

Market Cap	143.04B +498.0%
Revenue (ttm)	4.97B -24.7%
Net Income	-7.84B
EPS	-960.18
Shares Out	9.80M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	50,988
Open	16,790
Previous Close	16,790
Day's Range	15,880 - 17,640
52-Week Range	2,535 - 19,840
Beta	-0.26
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 13, 2026

About Celemics

Celemics, Inc. designs, manufactures, and distributes sequencing kits in South Korea. The company offers whole exome sequencing panels; NGS target enrichment panels; customized and ready-to-use enrichment panels; and modular accessories, including library preparation kits, double standard Cdna synthesis, hybridization enhancer, celan-up and streptavidin beads, CeleNM beads, and polymerase. It also provides celemics analysis, whole exome sequencing, customized NGS panels, sequencing, bioinformatics, biopharma, and custom NGS assay development se...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 2010
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 331920